BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 19026857)

  • 1. Recurrent ventricular arrhythmia storms in the age of implantable cardioverter defibrillator therapy: a comprehensive review.
    Huang DT; Traub D
    Prog Cardiovasc Dis; 2008; 51(3):229-36. PubMed ID: 19026857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of sudden cardiac death: the role of the implantable cardioverter-defibrillator.
    Sinha SK; Mehta D; Gomes JA
    Mt Sinai J Med; 2005 Jan; 72(1):1-9. PubMed ID: 15682255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable cardioverter-defibrillator: present and future indications.
    Block M; Scheld H; Breithardt G
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():141-7. PubMed ID: 8734176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrical storms and their prognostic implications.
    Awan ZA; ul Hassan M; Bangash K; Shah B; Noor L
    J Ayub Med Coll Abbottabad; 2009; 21(3):155-8. PubMed ID: 20929037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
    Proclemer A; Ghidina M
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096
    [No Abstract]   [Full Text] [Related]  

  • 6. [The implantable cardioverter/defibrillator].
    Kuck KH; Siebels J; Schlüter M; Meinertz T
    Herz; 1994 Oct; 19(5):287-93. PubMed ID: 8001901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Electrical storm in patients with implantable cardioverter-defibrillator].
    Mitręga K; Średniawa B; Kowalski O; Lenarczyk R; Musialik-Łydka A; Kalarus Z
    Kardiol Pol; 2013; 71(2):198-201; discussion 202. PubMed ID: 23575717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary hyperparathyroidism and arrhythmic storm in a patient with an implantable cardioverter defibrillator for primary prevention of sudden death.
    Occhetta E; Bortnik M; Magnani A; Francalacci G; Vassanelli C
    Europace; 2004 May; 6(3):184-8. PubMed ID: 15121067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia in patients with an implantable defibrillator warrants catheter ablation.
    Kuck KH
    Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):713-20; discussion 720. PubMed ID: 20009082
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.
    Kowey PR; Crijns HJ; Aliot EM; Capucci A; Kulakowski P; Radzik D; Roy D; Connolly SJ; Hohnloser SH;
    Circulation; 2011 Dec; 124(24):2649-60. PubMed ID: 22082672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?
    Ellenbogen KA; Levine JH; Berger RD; Daubert JP; Winters SL; Greenstein E; Shalaby A; Schaechter A; Subacius H; Kadish A;
    Circulation; 2006 Feb; 113(6):776-82. PubMed ID: 16461817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Implantable cardioverter-defibrillator(ICD)].
    Kurita T
    Nihon Rinsho; 2002 Jul; 60(7):1353-60. PubMed ID: 12136614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
    Connolly SJ; Hallstrom AP; Cappato R; Schron EB; Kuck KH; Zipes DP; Greene HL; Boczor S; Domanski M; Follmann D; Gent M; Roberts RS
    Eur Heart J; 2000 Dec; 21(24):2071-8. PubMed ID: 11102258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ventricular arrhythmia storm in the era of implantable cardioverter-defibrillator.
    Looi KL; Tang A; Agarwal S
    Postgrad Med J; 2015 Sep; 91(1079):519-26. PubMed ID: 26310265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of electrical storm as a mortality and morbidity risk factor and its clinical predictors: a meta-analysis.
    Guerra F; Shkoza M; Scappini L; Flori M; Capucci A
    Europace; 2014 Mar; 16(3):347-53. PubMed ID: 24096960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.
    Li CH; Lin YJ; Huang JL; Wu TJ; Cheng CC; Lin WS; Tuan TC; Chang SL; Lo LW; Hu YF; Chao TF; Chung FP; Tsai CF; Tsao HM; Chen SA
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):750-6. PubMed ID: 22353378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
    Bardy GH; Yee R; Jung W
    J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catheter ablation of electrical storm in a collaborative hospital network.
    Deneke T; Shin DI; Lawo T; Bösche L; Balta O; Anders H; Bünz K; Horlitz M; Grewe PH; Lemke B; Mügge A
    Am J Cardiol; 2011 Jul; 108(2):233-9. PubMed ID: 21529742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Implantable defibrillators--current status of guidelines. Recognized and possible indications--prerequisites].
    Andresen D
    Fortschr Med; 1996 Apr; 114(11):128-32. PubMed ID: 8682425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.